Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 95.36% | 77.52% | 113.01% | -4.63% | -964.15% |
| Total Depreciation and Amortization | 0.34% | -10.08% | -15.37% | 260.91% | -44.66% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 23.95% | 23.95% | 49.09% |
| Total Other Non-Cash Items | -92.58% | -27.69% | -39.12% | 133.66% | 1,432.88% |
| Change in Net Operating Assets | 6.61% | -183.73% | -131.53% | 19.68% | 25.11% |
| Cash from Operations | 79.40% | -23.48% | -23.34% | 323.29% | 6.14% |
| Capital Expenditure | 100.00% | 99.70% | 97.46% | -13.85% | -11,542.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -635.08% | -- | -- | -3,988.41% | 96.23% |
| Cash from Investing | 48.60% | 99.87% | 99.15% | -1,781.00% | 46.19% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.62% | 91.62% | -81.51% | 111.61% | 2.32% |
| Cash from Financing | -0.62% | 91.62% | -103.96% | 111.61% | -105.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.68% | 148.99% | -162.05% | 510.93% | -119.94% |